Investing.com
H.C. Wainwright reiterates Jade Biosciences stock rating at buy
H.C. Wainwright reiterates Jade Biosciences stock rating at buy
News
Not thousands of headlines. The few lines that move price. For traders: straight from the source, clear and simple.
Investing.com
Canaccord cuts Hillman Solutions stock price target on housing headwinds
Canaccord cuts Hillman Solutions stock price target on housing headwinds
Investing.com
Cantor Fitzgerald reiterates Micron stock rating on supply outlook
Cantor Fitzgerald reiterates Micron stock rating on supply outlook
Investing.com
Northland initiates Civeo stock with Outperform rating on infrastructure demand
Northland initiates Civeo stock with Outperform rating on infrastructure demand
Investing.com
Cantor Fitzgerald reiterates Nvidia stock rating on AI demand growth
Cantor Fitzgerald reiterates Nvidia stock rating on AI demand growth
Investing.com
Stephens cuts Cal-Maine Foods stock price target on weak margins
Stephens cuts Cal-Maine Foods stock price target on weak margins
Investing.com
H.C. Wainwright cuts ProQR stock price target on execution risks
H.C. Wainwright cuts ProQR stock price target on execution risks
Investing.com
H.C. Wainwright reiterates Syndax stock Buy rating at $38 target
H.C. Wainwright reiterates Syndax stock Buy rating at $38 target
CryptoCoinDesk
Crypto lost $1.26 billion in hacks while bitcoin bulls enjoyed a monster quarter
Your day-ahead look for Oct. 1, 2026
ForexForexLive
Trump tells TIME the U.S. could resume or intensify attacks against Iran after the midterm elections
According to the interview with TIME, Trump initially expected the conflict to last only four to six weeks, but seven months later there is still no clear end in sight. The conflict has disrupted oil flows through the Strait of Hormuz, pushed energy prices higher and created significant economic and geopolitical consequences. Trump continues to defend the decision to launch the war, arguing that…
StockMarketWatch
The stock market is a hollow tree that could be about to snap, warns bond king Gundlach
Stocks are facing a lot of issues right now, even if investors think everything looks great on the surface warns DoubleLine Capital’s Jeffrey Gundlach.
Investing.com
Kimberly-Clark announces executive changes ahead of Kenvue deal
Kimberly-Clark announces executive changes ahead of Kenvue deal
Investing.com
Idaho Strategic Resources reports drilling results at Golden Chest
Idaho Strategic Resources reports drilling results at Golden Chest
Investing.com
Edible Garden to acquire Iowa manufacturing facility property
Edible Garden to acquire Iowa manufacturing facility property
Investing.com
UnitedHealthcare unveils 2027 Medicare Advantage plans
UnitedHealthcare unveils 2027 Medicare Advantage plans
Investing.com
Unicycive appoints Meredith Manning to board of directors
Unicycive appoints Meredith Manning to board of directors
Investing.com
Lantronix module added to U.S. defense drone component list
Lantronix module added to U.S. defense drone component list
Investing.com
Shattuck Labs plans phase 2 trial for SL-325 in hidradenitis suppurativa
Shattuck Labs plans phase 2 trial for SL-325 in hidradenitis suppurativa
Investing.com
Foghorn ends FHD-909 program, cuts 40% of workforce
Foghorn ends FHD-909 program, cuts 40% of workforce
Investing.com
SharonAI secures $356m GPU-backed debt facility at 9.95%
SharonAI secures $356m GPU-backed debt facility at 9.95%
News text belongs to its source; only the headline and a short summary appear here.